Marshall Islands Tech Journal
SEE OTHER BRANDS

The best science and technology news from the Marshall Islands

Marshall Islands Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Marshall Islands Tech Journal.

Press releases published on August 1, 2025

Spryker remporte le 2025 Silver Stevie® Award for Technology Excellence (Stevie® Award d’Argent pour l’excellence technologique 2025) dans l’e-commerce

Spryker remporte le 2025 Silver Stevie® Award for Technology Excellence (Stevie® Award d’Argent pour l’excellence technologique 2025) dans l’e-commerce

BERLIN et NEW YORK, 01 août 2025 (GLOBE NEWSWIRE) -- Spryker, la plateforme mondiale d’e-commerce composable leader conçue spécialement pour répondre aux besoins des entreprises d’envergure mondiale, a annoncé aujourd’hui avoir remporté le Silver Stevie® …

24/7 Market News: 10 Reasons Siyata Mobile Is a Perfect Match for Core Gaming

24/7 Market News: 10 Reasons Siyata Mobile Is a Perfect Match for Core Gaming

DENVER, Aug. 01, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, highlights Siyata Mobile (NASDAQ: SYTA), a global developer and vendor of mission-critical …

SJCAM Launches C400 4K Action Camera with Detachable Design and Wireless Handheld Control

SJCAM Launches C400 4K Action Camera with Detachable Design and Wireless Handheld Control

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- SJCAM, a longtime pioneer in the action camera space, has officially announced its latest handheld action camera, C400, at the end of July 2025. SJCAM C400 is a next-generation action camera that redefines smart, …

Zscaler Completes Acquisition of Red Canary to Accelerate Innovations in Agentic AI-driven Security Operations

Zscaler Completes Acquisition of Red Canary to Accelerate Innovations in Agentic AI-driven Security Operations

SAN JOSE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced it has completed its acquisition of Red Canary. Together, the companies will deliver unified Security Operations, combining …

AI/R Accelerates Personalization at Scale Through Webjump’s Latest Adobe Milestone

AI/R Accelerates Personalization at Scale Through Webjump’s Latest Adobe Milestone

Webjump’s fifth Adobe specialization underscores its commitment to innovation and digital excellence as a Platinum Specialized Partner. SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- AI/R, the AI Revolution Company, today announced that its subsidiary, …

AI/R Acelera Personalização em Escala com o Último Marco em Adobe da Webjump

AI/R Acelera Personalização em Escala com o Último Marco em Adobe da Webjump

Quinta especialização em Adobe da Webjump ressalta seu compromisso com a inovação e a excelência digital como Platinum Specialized Partner. SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- A AI/R, a AI Revolution Company, anunciou hoje que sua subsidiária, …

Lunar Outpost and the LEGO Group Team Up for Out-Of-This World LEGO® Technic Set

Lunar Outpost and the LEGO Group Team Up for Out-Of-This World LEGO® Technic Set

  GOLDEN, Colo., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Lunar Outpost, a pioneer in planetary mobility and space resource utilization, and the LEGO Group have debuted the LEGO® Technic Lunar Outpost® Moon Rover Space Vehicle set. The out-of-this-world …

SecureTech Announces Uplisting to OTCQB Venture Market

SecureTech Announces Uplisting to OTCQB Venture Market

Roseville, Minnesota, Aug. 01, 2025 (GLOBE NEWSWIRE) -- SecureTech Innovations, Inc. (OTCQB: SCTH), a pioneering technology company advancing artificial intelligence, industrial 3D printing and manufacturing technologies, cybersecurity, and digital …

Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma

Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma

Lymphodepletion Regimen Selection Made in Conjunction with the ALPHA3 Data and Safety Monitoring Board (DSMB) and Steering Committee, and in Consultation with the FDA Following an ALLO-647-Related Death in the FCA (FC plus ALLO-647) Lymphodepletion Arm …

NordVPN launches Scam Call Protection feature for Android users in the US

NordVPN launches Scam Call Protection feature for Android users in the US

LONDON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Cybersecurity company NordVPN is rolling out a Scam Call Protection feature for Android users in the United States, giving people a new way to spot and dodge fraudulent calls and stay one step ahead of …

Ocugen Provides Business Update with Second Quarter 2025 Financial Results

Ocugen Provides Business Update with Second Quarter 2025 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET Initiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trial Actively dosing patients in OCU400 Phase 3 liMeliGhT clinical trial and on track for 2026 BLA filing OrthoCellix reverse …

I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares

I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares

ROCKVILLE, Md., Aug. 01, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the pricing of an …

Travel eSIM app Saily debuts Ultra, a new premium plan for unparalleled journeys

Travel eSIM app Saily debuts Ultra, a new premium plan for unparalleled journeys

LONDON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NordVPN’s travel eSIM app Saily is launching a premium subscription plan, Saily Ultra, which offers unlimited global eSIM data combined with special benefits for travelers. “The Saily Ultra plan is designed for …

Ascentage Pharma to Participate in Evercore China Biotech Summit

Ascentage Pharma to Participate in Evercore China Biotech Summit

ROCKVILLE, Md. and SUZHOU, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …

Orchestra BioMed Announces Pricing of $40 Million Public Offering

Orchestra BioMed Announces Pricing of $40 Million Public Offering

NEW HOPE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …

FOXO TECHNOLOGIES INC.’S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

FOXO TECHNOLOGIES INC.’S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, …

Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression

Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression

SOLANA BEACH, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (“Artelo” or the “Company”) (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with …

Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders

Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders

SAN DIEGO and TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF; OTCQB: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy …

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on August 1, 2025, it awarded …

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions